United States · Bill · S
S. 773 (104th)
Animal Drug Availability Act of 1996
Introduced
9 May 1995
Last action
26 September 1996 · Floor
Status
Held at the desk.
Sponsors
Sen. Kassebaum, Nancy Landon [R-KS], Sen. Gregg, Judd [R-NH], Sen. Gorton, Slade [R-WA], Sen. Coats, Daniel [R-IN], Sen. Jeffords, James M. [I-VT], Sen. Frist, William H. [R-TN], Sen. Harkin, Tom [D-IA], Sen. Craig, Larry E. [R-ID], Sen. Lugar, Richard G. [R-IN], Sen. Inhofe, James M. [R-OK], Sen. Grassley, Chuck [R-IA], Sen. McConnell, Mitch [R-KY], Sen. Kyl, Jon [R-AZ], Sen. Santorum, Rick [R-PA], Sen. Heflin, Howell [D-AL], Sen. Bond, Christopher S. [R-MO], Sen. Pryor, David H. [D-AR], Sen. Kerrey, J. Robert [D-NE], Sen. Bennett, Robert F. [R-UT], Sen. Helms, Jesse [R-NC], Sen. Hutchison, Kay Bailey [R-TX], Sen. Lott, Trent [R-MS], Sen. Dole, Robert J. [R-KS], Sen. Bumpers, Dale [D-AR], Sen. Mack, Connie, III [R-FL], Sen. Ashcroft, John [R-MO], Sen. Cochran, Thad [R-MS], Sen. Roth Jr., William V. [R-DE], Sen. Warner, John [R-VA], Sen. Ford, Wendell H. [D-KY], Sen. Kempthorne, Dirk [R-ID], Sen. Robb, Charles S. [D-VA], Sen. Pressler, Larry [R-SD], Sen. Nickles, Don [R-OK], Sen. Stevens, Ted [R-AK], Sen. Abraham, Spencer [R-MI], Sen. Daschle, Thomas A. [D-SD], Sen. Grams, Rod [R-MN], Sen. Conrad, Kent [D-ND], Sen. Burns, Conrad R. [R-MT], Sen. Moseley-Braun, Carol [D-IL], Sen. Dorgan, Byron L. [D-ND], Sen. Baucus, Max [D-MT], Sen. Hatch, Orrin G. [R-UT], Sen. Coverdell, Paul [R-GA]
Subjects
Healthcare
Source updated
21 April 2025
Summary
Animal Drug Availability Act of 1995 - Amends Federal Food, Drug, and Cosmetic Act provisions relating to new animal drugs to redefine "substantial evidence" to mean evidence from one or more scientifically sound studies including, as appropriate, in vitro studies, studies in laboratory animals, bioequivalence studies, tissue residue studies, and any studies voluntarily undertaken by or for the applicant that provide some assurance that the drug will have the intended effect. Excludes a claim for the use of a drug in a minor species or a minor use of a drug from disapproval, if there is an application filed for the drug which is approved prior to the submission of the claim. Directs the Secretary of Health and Human Services to consider the following issues when a new animal drug contains more than one active ingredient, or the labeling of the drug suggests use of the drug in combination with another animal drug: (1) whether any active ingredient or any combination of drugs alters the safe concentration of another of the active ingredients or drugs in the combination; (2) whether each of the active ingredients or drugs in the combination have been shown to contribute to the same intended effect; and (3) whether each of the active ingredients or drugs in the combination has an identified target population for which dosing with the active ingredients or combination represents appropriate concurrent therapy. Requires the Secretary to issue proposed regulations implementing the provisions of this section which: (1) further define "substantial evidence"; (2) take into account the proposals contained in the citizen petition submitted by the American Veterinary Association and the Animal Health Institute; (3) provide for a conference to make a decision establishing a submission or an investigational requirement; and (4) define the kinds of evidence an applicant may use to establish the contribution of each active ingredient and to establish the appropriateness of concurrent therapy in a new animal drug, or new animal drug used in combination with another drug. (Sec. 4) Requires the Secretary to approve or disapprove the application within 90 (currently 180) days of receipt of the application. (Sec. 5) Requires: (1) the Secretary to refer disputed issues received in writing from an applicant to an advisory committee or to a special Government employee; and (2) the committee or employee to submit a report containing recommendations regarding the matter. (Sec. 6) Requires the Secretary to refuse approval of an application if information submitted with respect to the drug indicates that any use suggested in labeling proposed for that drug will result in a unsafe amount of residue. (Sec. 7) Permits the export of an unsafe (as defined in the Act) new animal drug, if it is not in conflict with the laws of the country to which it is exported. (Currently, such export is prohibited.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 May 1995
Introduced
Read twice and referred to the Committee on Labor and Human Resources.
Source: IntroReferral
9 May 1995
Introduced
Introduced in Senate
Source: IntroReferral
9 May 1995
Introduced
Sponsor introductory remarks on measure. (CR S6351-6352)
Source: IntroReferral
24 September 1996
Floor
Measure laid before Senate. (consideration: CR S11204-11209)
Source: Floor
24 September 1996
Passed
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Source: Floor
24 September 1996
Discharge
Senate Committee on Labor and Human Resources discharged by Unanimous Consent.
Source: Discharge
24 September 1996
Committee
Senate Committee on Labor and Human Resources discharged by Unanimous Consent.
Source: Committee
26 September 1996
Floor
Held at the desk.
Source: Floor
26 September 1996
Floor
Message on Senate action sent to the House.
Source: Floor
26 September 1996
Floor
Received in the House.
Source: Floor
Votes
No vote records are attached yet.
Versions
- Engrossed in Senate · 24 September 1996 · Download file
- Introduced in Senate · 9 May 1995 · Download file
Documents
6 official files
Engrossed in Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in Senate (text)
Engrossed in Senate · EN · 24 September 1996
Engrossed in Senate (PDF)
Engrossed in Senate · EN · 24 September 1996
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Passed Senate amended
summary · EN · 24 September 1996
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (text)
Introduced in Senate · EN · 9 May 1995
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate (PDF)
Introduced in Senate · EN · 9 May 1995
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 9 May 1995
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Kassebaum, Nancy Landon [R-KS] · R · Sponsor
- Sen. Gregg, Judd [R-NH] · R · Sponsor
- Sen. Gorton, Slade [R-WA] · R · Sponsor
- Sen. Coats, Daniel [R-IN] · R · Sponsor
- Sen. Jeffords, James M. [I-VT] · R · Sponsor
- Sen. Frist, William H. [R-TN] · R · Sponsor
- Sen. Harkin, Tom [D-IA] · D · Sponsor
- Sen. Craig, Larry E. [R-ID] · R · Sponsor
- Sen. Lugar, Richard G. [R-IN] · R · Sponsor
- Sen. Inhofe, James M. [R-OK] · R · Sponsor
- Sen. Grassley, Chuck [R-IA] · R · Sponsor
- Sen. McConnell, Mitch [R-KY] · R · Sponsor
- Sen. Kyl, Jon [R-AZ] · R · Sponsor
- Sen. Santorum, Rick [R-PA] · R · Sponsor
- Sen. Heflin, Howell [D-AL] · D · Sponsor
- Sen. Bond, Christopher S. [R-MO] · R · Sponsor
- Sen. Pryor, David H. [D-AR] · D · Sponsor
- Sen. Kerrey, J. Robert [D-NE] · D · Sponsor
- Sen. Bennett, Robert F. [R-UT] · R · Sponsor
- Sen. Helms, Jesse [R-NC] · R · Sponsor
- Sen. Hutchison, Kay Bailey [R-TX] · R · Cosponsor
- Sen. Lott, Trent [R-MS] · R · Cosponsor
- Sen. Dole, Robert J. [R-KS] · R · Cosponsor
- Sen. Bumpers, Dale [D-AR] · D · Cosponsor
- Sen. Mack, Connie, III [R-FL] · R · Cosponsor
- Sen. Ashcroft, John [R-MO] · R · Cosponsor
- Sen. Cochran, Thad [R-MS] · R · Cosponsor
- Sen. Roth Jr., William V. [R-DE] · R · Cosponsor
- Sen. Warner, John [R-VA] · R · Cosponsor
- Sen. Ford, Wendell H. [D-KY] · D · Cosponsor
- Sen. Kempthorne, Dirk [R-ID] · R · Cosponsor
- Sen. Robb, Charles S. [D-VA] · D · Cosponsor
- Sen. Pressler, Larry [R-SD] · R · Cosponsor
- Sen. Nickles, Don [R-OK] · R · Cosponsor
- Sen. Stevens, Ted [R-AK] · R · Cosponsor
- Sen. Abraham, Spencer [R-MI] · R · Cosponsor
- Sen. Daschle, Thomas A. [D-SD] · D · Cosponsor
- Sen. Grams, Rod [R-MN] · R · Cosponsor
- Sen. Conrad, Kent [D-ND] · D · Cosponsor
- Sen. Burns, Conrad R. [R-MT] · R · Cosponsor
- Sen. Moseley-Braun, Carol [D-IL] · D · Cosponsor
- Sen. Dorgan, Byron L. [D-ND] · D · Cosponsor
- Sen. Baucus, Max [D-MT] · D · Cosponsor
- Sen. Hatch, Orrin G. [R-UT] · R · Cosponsor
- Sen. Coverdell, Paul [R-GA] · R · Cosponsor
- · sshr00 · Standing
Related records
- related to → Animal Drug Availability Act of 1996
- amends ← To provide for a substitute amendment.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/104th-congress/senate-bill/773
- Open data entity: https://api.congress.gov/v3/bill/104/s/773
- us · 104-s-773 · source updated 21 April 2025